Care Priorities
/
GLP-1 & Metabolic Care
Care priority · High-cost and complex care

Connect coverage policy to the care that follows.

Apply the plan’s documented benefit and PBM rules, then present the prescribing clinicians, pharmacy arrangements and metabolic-care programs the plan already offers. Clinical eligibility and prescriptions remain clinician decisions.

Illustrative governance application
Published market signal
18%

of firms with 200 or more workers that offer health benefits covered GLP-1 agonists primarily for weight loss in their largest plan in 2026.

Limitation: Measures large-firm coverage policy. It says nothing about utilization, cost or clinical results.

Source: KFF, 2026 Employer Health Benefits Survey ↗

Why it matters to self-funded plans

GLP-1 coverage is usually decided in plan design and PBM policy, while the care that follows happens elsewhere: with a prescriber, a pharmacy and sometimes a nutrition or lifestyle program. The plan rarely sees how those pieces connect.

Governance can help the plan apply its stated rules consistently, point members to resources it already pays for, and see whether each handoff was acknowledged.

01 · Sponsor decisions

What the plan may configure

How the plan’s documented GLP-1 benefit and PBM criteria are applied at entry
Which prescribing clinicians and pharmacy arrangements are presented
Which nutrition, lifestyle or metabolic programs are offered alongside
What continuation information the plan may receive, as permitted
Which cases return to the plan or PBM for review
02 · Existing destinations

Illustrative care destinations

Prescribing clinicians in the plan’s network
Pharmacy arrangements under the plan’s PBM
Nutrition and lifestyle programs the plan offers
Metabolic or weight-management programs already under contract

The PPO network and the standard PBM process stay available.

03 · Evidence

What partner response and encounter evidence should return

Coverage review recorded
Program enrollment
Handoff acknowledgment
Pharmacy claims or approved partner-reported evidence, where available under applicable data-sharing agreements
Permitted continuation information
Later pharmacy claims reconciliation
04 · Before deployment

What must be validated first

The plan’s GLP-1 coverage terms and PBM criteria are documented
Each destination agrees to acknowledge referrals within set timelines
Data-sharing and privacy terms are in place with the administrator and partners
Clinical escalation rules are reviewed by qualified clinicians
Available claims data supports later reconciliation
Member communications are reviewed by the plan and its advisor

This page describes an illustrative governance application, not a deployed pathway. Deployment depends on plan-specific applicability, partner capacity, authority and validated workflows. See current product maturity →

Start with the plan’s agreements and available claims.

The Control Tower assessment establishes the plan’s baseline and helps determine which care priorities may warrant governance.